Earnings dates and session timing shown here are aggregated from third-party sources, are frequently estimated, and are subject to change or confirmation by the reporting company. Nothing on this site is financial advice.
Silo Pharma Inc. is a pioneering biopharmaceutical company dedicated to innovating therapeutics by integrating traditional treatment approaches with psychedelic research, focusing on mental health disorders and rare diseases. Utilizing its proprietary drug delivery technologies and forming strategic alliances, Silo aims to ensure the responsible clinical application of psychedelics within a regulatory framework. With a promising pipeline of candidates addressing significant unmet medical needs, Silo Pharma is well-positioned to capitalize on the growing interest in mental health therapeutics, offering potential value creation for investors in this dynamic sector.
Quotes and fundamental data are delayed and provided for informational purposes only — nothing on this page is financial advice. Figures are as reported by the company and its data providers and may be revised. Estimates reflect analyst consensus at the time of each report.
$2.35
| Quarter | EPS | Revenue | Price move | |||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Est | Adj | Result | GAAP | Est | Actual | Surprise | 1D Pre | On-Day | 1D Post | |
Q ended Jun 30, 2026 Reported Aug 13, 2026 | — | $-0.76 | — | $-0.76 | — | $0 | — | 1D Pre-13.1% | On-Day+4.0% | 1D Post-0.6% |
Q ended Mar 31, 2026 Reported May 13, 2026 | — | $-1.80 | — | $-0.12 | — | $18.0K | — | 1D Pre+1.5% | On-Day-1.4% | 1D Post+0.9% |
Q ended Dec 31, 2025 Report date n/a | — | |||||||||
Dashed outlines show the analyst consensus estimate for periods where one was published. Hover or tap a bar for exact figures. Values as reported; not adjusted for splits after the report date.
| — |
| — |
| — |
| — |
| $18.0K |
| — |
| 1D Pre— |
| On-Day— |
| 1D Post— |
Q ended Sep 30, 2025 Reported Nov 13, 2025 | $0.00 | $-0.11 | Miss | — | — | $18.0K | — | 1D Pre-3.0% | On-Day-3.6% | 1D Post-5.1% |